doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: cob

1 - 5 of 18 <<previous | next>>

Drugs results:

Atorvastatin

Atorvastatin

Atorvastatin belong to a class of drug known as HMG CoA reductase inhibitor. This drug works by blocking the production of cholesterol (a type of fat) in the body. Indications: to reduce the amounts of low density lipoprotein or LDL (bad) cholesterol, more...

Esomeprazole pill

Esomeprazole

Esomeprazole belong to a class of drug known as proton pump inhibitor that works by decreasing the amount of hydrochloric acid produced by the parietal cells in the stomach. Indications: treatment of gastroesophageal reflux disease (GERD) and erosive more...

Zithromax tablets

Zithromax

Zithromax, also called Azithromycin, is used to treat bacterial infections in many different parts of the body. It is also used to prevent Mycobacterium Avium Complex (MAC) disease in patients infected with the Human Immunodeficiency Virus (HIV). It works more...

Lansoprazole pills

Lansoprazole

Lansoprazole belong to a class of drug known as proton pump inhibitor (PPI). It works by decreasing the amount of acid produced in the stomach. Lansoprazole is used to treat and prevent stomach and intestinal ulcers, erosive esophagitis (damage to the e more...

Rosuvastatin pills

Rosuvastatin

Rosuvastatin is an HMG CoA reductase inhibitor which is also known as “statins” group. A class of drug that works by blocking the production of cholesterol (a type of fat) in the body. Indications: for primary hypercholesterolemia (excessive choleteste more...

Diseases results:

Reduce cholesterol
Flatulence
Lung diseases
Zollinger Ellison Syndrome
Stomach ulcer
Peptic ulcer
Allergic conjunctivitis
Dyspepsia
Gastric ulcer

Articles results:

Los Angeles Times Examines FDA Funding Levels
An FDA study on the cardiovascular risks of attention deficit hyperactivity disorder drugs might be "halted in midstream" because the "agency doesn't have the money to finish it," the Los Angeles Times reports. According to the Times, the "threat to the study ...


EU Institutions Press For Early Adoption Of Advanced Therapies Regulation
This morning, the European Institutions indicated a strong willingness to get an early agreement on the Advanced Therapies Regulation at a press conference organized by EuropaBio. The European biotechnology industry, represented by EuropaBio, is calling for the smooth adoption of the "Advanced Therapies" Regulation and is encouraging the European Parliament to support the position of the Environment (ENVI) Committee to achieve this, when they vote in Plenary on 13th March.


Accidental Poisonings Can Happen During Day-to-Day Routines
With more than 90 percent of poisonings occurring in the home and more than 19 million Americans caring for someone over the age of 75, caregivers and family members of children and seniors play a critical role in prevention of poisonings. The American Society of Health-System Pharmacists (ASHP) recognizes the importance of providing caregivers with poison prevention information during National Poison Prevention Week, March 18-24.


Senate Committee Approves Bill To Reauthorize Prescription Drug User Fee Act
The Senate Health, Education, Labor and Pensions Committee on Wednesday voted 14-5 to approve a bill (S 1082) that would reauthorize the Prescription Drug User Fee Act, which will expire on Sept. 30, through 2012, Dow Jones reports. Earlier this year, FDA submitted to Congress a


Senate Passage Of FDA Revitalization Act Is Positive Step For Consumers, USA - Generic Pharmaceutical Association
The Generic Pharmaceutical Association (GPhA) todaycalled Senate passage of the Food and Drug Administration (FDA)Revitalization Act a step in the right direction for providing consumerswith greater access to safe and affordable generic medicines. GPhApointed to the inclusion of an amendment to curb abuse of the citizenpetition process and an agreement to continue working on biogenericslegislation before the Act goes to conference with the House ofRepresentatives.




1 - 5 of 18 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.